Generate a tailored SOP for Dr. Christine Bestvina. Improve your application with a focused, well-structured draft.
Christine Bestvina, MD, is an Associate Professor in the Department of Medicine at the University of Chicago, specializing in the treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer. With expertise in immunotherapy, targeted therapy, and the integration of ablative radiotherapy, Dr. Bestvina is also the Associate Director of Clinical Operations in Thoracic Oncology at the University of Chicago Medicine. She leads multiple investigator-initiated cooperative-group clinical trials and serves as the National Principal Investigator for key studies evaluating innovative treatment modalities. An active contributor to national and international leadership in thoracic oncology, she is involved with organizations such as the International Association for the Study of Lung Cancer and the American Society of Clinical Oncology. Recognition includes being listed in Chicago Magazine’s Top Doctors from 2023 onward. Dr. Bestvina has authored numerous peer-reviewed publications addressing clinical trial innovation, mechanisms of treatment resistance, and biomarker-driven precision medicine. Committed to education and mentorship, she has received multiple institutional teaching awards for her dedication to advancing patient-centered research and improving outcomes for individuals with thoracic malignancies.
University of Chicago Medicine • Chicago, IL
Oversees clinical operations in thoracic oncology, managing clinical trials and patient care activities.
Department of Philosophy